
Ptosis (pronounced to'sis) simply means droopy eyelid. It is one of the most common eyelid problems. The lid may droop slightly, or cover the entire pupil, which can restrict and even block normal vision. It can be present in children and adults, and is usually treated with surgery.
There is a difference between a droopy eyelid and a baggy eyelid. A droopy eyelid is low. A baggy eyelid (dermatochalasis) has excess skin and fat. The two often occur at the same time in adults.
Ptosis can be inherited, be present at birth, occur later in life, and affect one or both eyelids. Signs and symptoms include: the drooping lid itself, looking up underneath drooping lids (a "chin-up posture"), raising the eyebrows in an attempt to lift the lids, loss of interest in reading due to forehead muscle fatigue, and headaches due to forehead muscle fatigue.
The most common cause of ptosis in adults is the separation of the levator muscle from the eyelid. This may occur due to aging changes, after an injury to the eyelid, after eye surgery such as cataract surgery, or with an eyelid tumor. Less commonly, ptosis in adults may occur with neurological disorders. Additional testing is performed to help diagnose these conditions.
Treatment is usually surgical and involves tightening of the levator (lifting) muscle within the eyelid (external levator advancement). This is performed as a same day surgery with light sedation and local anesthesia. If necessary, a blepharoplasty is performed first. Otherwise, a small incision is made in the natural upper lid skin crease. The levator muscle is tightened using a small, permanent suture. The patient is asked to open her eyes so that lid height, symmetry, and contour can be assessed.
It is important for the patient to be alert during this part of the surgery to give the best results. Further adjustments are made, if necessary. The incision is closed using a fine absorbable suture. The patient is seen for a postoperative visit 1 week later. Sometimes, the lid height will need adjusting at that visit, which is comfortably performed in the office under local anesthesia.
Tearing can be a difficult problem for both patient and doctor alike. Tearing, which is the actual spilling of tears down the cheek, differs from "watering," where tears well up without spilling down the cheek. The distinction between tearing and watering is important, because tearing implies a partial or complete blockage somewhere along the tear drainage system, such as a nasolacrimal duct obstruction (a plumbing problem). Watering implies a problem with the eyelids or the tear film. Watering eyes can be caused by eyelid malpositioning, such as ectropion (out-turned lid) and entropion (in-turned lid). In either case, the lower punctum (opening in the lower eyelid to collect tears) is not in the proper position to collect the tears.
It is important to understand that multiple factors can simultaneously contribute to tearing: tear film abnormalities, eyelid malposition, and nasolacrimal duct obstruction. Thus, a thorough exam in the office is necessary to determine which factors contribute to a patient's tearing problem.
The tear film is composed of three layers: outer (oil) layer, middle aqueous (water) layer, and inner layer (mucin) layer. The oil layer serves to keep the middle aqueous layer from evaporating. The mucin layer acts as a lubricant on the ocular surface. A deficiency in any or all of these layers can lead to eye irritation and watering.
Tears are primarily made from the lacrimal gland, which is located in the outside corner of the orbit (eye socket). Tears are distributed over the ocular surface with each blink, much like a windshield wiper on a car's windshield. The tear film is an important component of the eye's optical system. Thus, an abnormality of the tear film can cause blurry vision as well as irritated, dry eyes and reflex tearing.
The tear drainage system begins at the inner corner of the upper and lower eyelids. Small openings called puncta on the inner margins of the lids collect the tears, which then drain through passageways called canaliculi into the nasolacrimal sac. The sac is located between the inner corner of the eyelids and the bridge of the nose. The nasolacrimal sac empties in the nasolacrimal duct, which is a bony passageway into the nose. Tears are then swallowed.
A blockage can occur anywhere along the drainage system, from the puncta to the canaliculi, to the nasolacrimal sac and finally the nasolacrimal duct into the nose.
If only the punctal openings are blocked, a simple procedure called a punctoplasty is performed in the office under local anesthesia. More often, though, a blockage exists further downstream, usually in the nasolacrimal duct.
Examination in the office is used to determine where along this pathway a blockage may exist in a patient with tearing.
Dacryocystitis (infection of the tear sac) may occur with a nasolacrimal duct obstruction. Symptoms can range from mild redness and irritation on the inside corner of the eyelids to a severe cellulitis requiring emergent care. Antibiotics are used in the short term, but ultimately a dacryocystorhinostomy (DCR) is necessary to prevent the infection from recurring.
A procedure called a dacryosystorhinostomy, otherwise known as a DCR, is used to alleviate tearing caused by a nasolacrimal duct obstruction. Dacryocysto means "tear sac", and rhinostomy means "opening to nose." The purpose of a DCR is to create a new pathway for the tears to enter the nose directly from the nasolacrimal sac, effectively bypassing the blocked nasolacrimal duct. This is accomplished through a small incision near the inside corner of the eyelids. The incision is hidden in a skin crease, and scarring is rarely an issue. A new connection is made between the nasolacrimal sac and the nose, thus allowing tears to directly enter the nose. A DCR is a same-day surgery under local with sedation and local anesthesia.
Blepharoplasty (Blepharo- means "eyelid", and -plasty means "change") is the most commonly performed facial plastic surgery procedure. This is because the eyelids account for a large part of the expressiveness of the face. When you look at someone, you look at his or her eyes. If the eyelids are sagging, droopy, or puffy, the face will look fatigued, sad, and tired despite good health and adequate rest. If the eyes look bright and alert, an otherwise aging face will appear rejuvenated. Thus, blepharoplasty is a procedure that can rejuvenate the face as well as the eyes.
Years ago, treatment focused on aggressive skin and fat removal on every patient. This approach lead to unnecessary complications, such as lid retraction after excessive skin removal, causing chronically irritated eyes, and a sunken (skeletonized) appearance to the eye socket after excessive fat removal. These results, unfortunately, created a more aged appearance - the direct opposite what was intended.
Today, blepharoplasty is tailored individually for each patient. The right combination of skin removal, skin resurfacing, fat removal, fat repositioning, and lid tightening is applied to achieve a more rejuvenated and youthful appearance in each individual patient. Sometimes, less is more.
Modern day upper lid blepharoplasty is typically performed as a same day surgery under light sedation and local anesthesia. An incision is made in the natural upper-lid skin crease, across the lid. Excess skin is removed using an advanced electrocautery device with the precision of a laser. Bulging orbital fat may be removed, sculpted, or repositioned. Lateral sub-brow fat that contributes to upper lid fullness may be removed and/or sculpted. The incision is closed using a fine, absorbable suture.
Modern day lower-lid blepharoplasty is performed to soften the puffiness of the lower eyelids caused by prolapsed orbital fat. An incision is made across the length of the inside of the lower lid to remove or sculpt the fat (transconjunctival blepharoplasty). Fat may be repositioned to improve a tear trough deformity. Excess skin is removed, if necessary. Lower lid laxity or droop may be simultaneously corrected. Blending of the lid-cheek junction is performed with a lateral canthoplasty and orbicularis muscle suspension.
Nonspecific orbital inflammation (NSOI), also known as psuedotumor, is disease of the eye that not uncommonly presents to the emergency room or ophthalmologist. Typically, its onset is acute and manifests with severe orbital pain, swelling around the eyes, limitation and pain with eye movements, and even loss of vision. It is easily confused with infection (pre-septal or post-septal eyelid cellulitis) and may be treated initially --and unsuccessfully-- with antibiotics.
Computed tomography of the orbits may reveal thickening of the extraocular muscles, stranding of the orbital fat, a poorly defined mass (hence the name "pseudotumor"), thickening of the sclera, soft tissue inflammation in the eyelids, or even nothing at all. NSOI can affect children as well as adults. Typically, it responds very quickly to high dose corticosteroids. In fact, this rapid response usually confirms the diagnosis. Atypical presentations warrant further testing, including blood tests and tissue biopsy.
NSOI is so named because of the way a biopsy of affected tissue appears microscopically. There is a scattering of plasma cells, lymphocytes, neutrophils, and histiocytes with no particular pattern. The differential diagnosis for pseudotumor includes the following: thyroid-associated orbitopathy (Graves' disease), non-infectious granulomatous inflammation (specific orbital inflammation such as Wegener's granulomatosis and sarcoidosis), infectious orbital inflammation (bacterial, fungal, and parasitic), lymphocytic inflammation (Sjogren's syndrome and Kimura's disease), xanthogranulomatous and histiocytic inflammations (non-Langerhans cell histiocytosis and Langerhans cell histiocytosis), fibrotic inflammation (idiopathic sclerosing orbital inflammation and chronic dacryocystitis), and amyloid deposition.
The treatment for NSOI is immunosuppression. Typically, high dose oral prednisone at 60-80 mg a day is tapered over a long period of months. Occasionally, patients may become steroid dependent and unable to be weaned from the prednisone without relapses. Alternative treatments include other forms of immunosuppression, such as methotrexate and immunomodulators such as infliximab. Irradiation of the orbit is also an option, although a tissue diagnosis should be obtained before pursuing radiation treatment. Irradiation is contraindicated in patients with diabetes, due to potential worsening of diabetic retinopathy.